The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Jacek Wójcikowski

Polish Academy of Sciences

Institute of Pharmacology

Kraków

Poland

[email]@*.krakow.pl

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Polish Academy of Sciences, Institute of Pharmacology, Kraków, Poland. 2002 - 2011
  • Department of Pharmacokinetics and Drug Metabolism, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, Poland. 2002 - 2009

References

  1. The role of the nervous system in the regulation of liver cytochrome p450. Wójcikowski, J., Daniel, W.A. Curr. Drug Metab. (2011) [Pubmed]
  2. Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver--A comparison with other phenothiazines. Wójcikowski, J., Boksa, J., Daniel, W.A. Biochem. Pharmacol. (2010) [Pubmed]
  3. Influence of antidepressant drugs on chlorpromazine metabolism in human liver--an in vitro study. Wójcikowski, J., Daniel, W.A. Pharmacol. Rep (2010) [Pubmed]
  4. Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism--an in vitro study. Wójcikowski, J., Daniel, W.A. Pharmacol. Rep (2009) [Pubmed]
  5. The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat. Wójcikowski, J., Daniel, W.A. Expert. Opin. Drug. Metab. Toxicol (2009) [Pubmed]
  6. Identification of factors mediating the effect of the brain dopaminergic system on the expression of cytochrome P450 in the liver. Wójcikowski, J., Daniel, W.A. Pharmacol. Rep (2008) [Pubmed]
  7. Regulation of liver cytochrome P450 by activation of brain dopaminergic system: physiological and pharmacological implications. Wójcikowski, J., Gołembiowska, K., Daniel, W.A. Biochem. Pharmacol. (2008) [Pubmed]
  8. The regulation of liver cytochrome p450 by the brain dopaminergic system. Wójcikowski, J., Gołembiowska, K., Daniel, W.A. Curr. Drug Metab. (2007) [Pubmed]
  9. Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine. Wójcikowski, J., Maurel, P., Daniel, W.A. Drug Metab. Dispos. (2006) [Pubmed]
  10. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes. Wójcikowski, J., Pichard-Garcia, L., Maurel, P., Daniel, W.A. Eur. Neuropsychopharmacol (2004) [Pubmed]
  11. Potential role of the brain dopaminergic system in the regulation of cytochrome P-450 expression. Wójcikowski, J. Pol. J. Pharmacol (2004) [Pubmed]
  12. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine. Wójcikowski, J., Pichard-Garcia, L., Maurel, P., Daniel, W.A. Br. J. Pharmacol. (2003) [Pubmed]
  13. Effects of cytochrome P-450 inducers on the perazine metabolism in a primary culture of human hepatocytes. Wójcikowski, J., Pichard-Garcia, L., Maurel, P., Daniel, W.A. Pol. J. Pharmacol (2003) [Pubmed]
  14. Perazine as a potent inhibitor of human CYP1A2 but not CYP3A4. Wójcikowski, J., Pichard-Garcia, L., Maurel, P., Daniel, W.A. Pol. J. Pharmacol (2002) [Pubmed]
  15. Thioridazine-fluoxetine interaction at the level of the distribution process in vivo. Wójcikowski, J., Daniel, W.A. Pol. J. Pharmacol (2002) [Pubmed]
 
WikiGenes - Universities